Medicine and Dentistry
Rhabdomyosarcoma
89%
Mutant
52%
Combination Therapy
41%
Trametinib
38%
Cells
35%
Antibody
28%
Epidermal Growth Factor Receptor
28%
Therapeutic Procedure
27%
Neoplasm
24%
Xenograft
23%
Oncogene
20%
Differentiation
19%
Malignant Neoplasm
18%
Programmed Cell Death
16%
Patient
16%
Cyclophosphamide
15%
Vincristine
15%
Dactinomycin
15%
Ras
15%
Dependent Personality Disorder
15%
Pediatric Cancer
15%
Selectivity
15%
Ganitumab
15%
Somatomedin C Receptor
15%
Pancreas Cancer
13%
Development
13%
Cell Line
12%
Pediatrics
12%
Clinical Trial
12%
Cell Growth
12%
Tumor Progression
11%
Radiosensitivity
11%
Tumor Xenograft
10%
Mitogen-Activated Protein Kinase
10%
Cancer
10%
Phosphorylation
10%
Tumor Regression
10%
Family
9%
Ionizing Radiation
9%
Assessment
9%
Gene
9%
Drug Resistance
8%
Event Free Survival
8%
MEK Inhibitor
8%
Growth
7%
Tipifarnib
7%
Exercise
7%
Western Blot
7%
Mitogen-Activated Protein Kinase
7%
Pediatrics Patient
7%
Biochemistry, Genetics and Molecular Biology
P53
100%
Mutant
55%
KRAS
33%
Oncogene
31%
HRAS
31%
Retinoic Acid
29%
Apoptosis
28%
SNAI2
25%
Nutlin
25%
Degradation
23%
Radiation
23%
Small Molecule
19%
Protein
18%
Mutation
18%
Farnesylation
17%
Phosphorylation
16%
Epidermal Growth Factor Receptor
15%
Isoform
15%
P73
15%
Cyclin D1
15%
Insulin-Like Growth Factor 1 Receptor
15%
Nested Gene
15%
Electric Potential
14%
Self Concept
14%
Growth
14%
Antibody
13%
Protein Stability
13%
Mitochondrion
13%
Myeloid
12%
Wild Type
12%
Farnesyltransferase
11%
Cell Death
11%
Solid
10%
Defense Mechanism
9%
Protein Kinase
8%
Mouse Model
7%
Trametinib
7%
Regulatory Mechanism
7%
Transcription
6%
Senescence
6%
Cell Growth
6%
Survival
6%
Autophosphorylation
6%
Kinase
6%
Aptitude
5%
Germ Cell
5%
Cisplatin
5%
Prenylation
5%
Radiosensitivity
5%
DNA-binding Domain
5%
Pharmacology, Toxicology and Pharmaceutical Science
Rhabdomyosarcoma
54%
Protein P53
46%
Trametinib
38%
Nutlin
25%
Neoplasm
21%
Ionizing Radiation
15%
Cyclophosphamide
15%
Cyclin D1
15%
Dactinomycin
15%
Vincristine
15%
Ganitumab
15%
Somatomedin C Receptor
15%
Apoptosis
15%
Retinoic Acid
13%
Antibody
13%
Tanespimycin
10%
Dependent Personality Disorder
10%
Tumor Growth
10%
Embryonal Carcinoma
9%
Tumor Regression
9%
Event Free Survival
8%
Mitogen Activated Protein Kinase Kinase Inhibitor
8%
Mouse
7%
Drug Resistance
7%
Malignant Neoplasm
7%
Sarcoma
5%
Cisplatin
5%
Germ Cell Tumor
5%